Charles Schwab’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $254K | Sell |
115,263
-35,158
| -23% | -$77.3K | ﹤0.01% | 3351 |
|
|
2025
Q1 | $325K | Sell |
150,421
-4,410
| -3% | -$9.53K | ﹤0.01% | 3189 |
|
|
2024
Q4 | $655K | Sell |
154,831
-32,137
| -17% | -$136K | ﹤0.01% | 3059 |
|
|
2024
Q3 | $2.14M | Buy |
186,968
+120,779
| +182% | +$1.38M | ﹤0.01% | 2692 |
|
|
2024
Q2 | $708K | Buy |
66,189
+21,158
| +47% | +$226K | ﹤0.01% | 3051 |
|
|
2024
Q1 | $691K | Buy |
+45,031
| New | +$691K | ﹤0.01% | 2907 |
|